NexImmune (NEXI)
OTHER OTC:NEXI
Holding NEXI?
Track your performance easily

NexImmune (NEXI) Income Statement

163 Followers

NexImmune Income Statement

Last quarter (Q2 2024), NexImmune's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, NexImmune's net income was $-2.33M. See NexImmune’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 24.05M$ 32.28M$ -63.08M$ -53.26M$ 27.85M$ 20.89M
Operating Income
$ -24.05M$ -32.97M$ -63.08M$ -53.26M$ -27.85M$ -20.89M
Net Non Operating Interest Income Expense
$ 424.88K$ 698.39K$ 664.37K$ -852.82K$ -1.66M$ 246.78K
Other Income Expense
$ -2.65M$ -759.93K$ 87.68K$ -3.21M$ -352.51K$ 92.28K
Pretax Income
$ -20.19M$ -32.34M$ -62.51M$ -51.28M$ -29.87M$ -20.55M
Tax Provision
-$ -4.98M$ -12.34M$ -13.90M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -22.82M$ -32.34M$ -62.51M$ -51.28M$ -33.15M$ -23.21M
Basic EPS
$ -13.84$ -30.82$ -2.60$ -2.54$ -1.68$ -2.10
Diluted EPS
$ -13.84$ -30.82$ -2.60$ -2.54$ -1.68$ -2.10
Basic Average Shares
$ 29.76M$ 1.05M$ 24.06M$ 20.19M$ 19.77M$ 9.77M
Diluted Average Shares
$ 29.76M$ 1.05M$ 24.06M$ 20.19M$ 19.77M$ 9.77M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 24.05M$ 32.28M$ -63.08M$ -53.26M$ 27.85M$ 20.89M
Net Income From Continuing And Discontinued Operation
$ -22.82M$ -32.34M$ -62.51M$ -51.28M$ -29.87M$ -20.55M
Normalized Income
$ -16.51M---$ -29.42M$ -20.55M
Interest Expense
----$ 1.68M$ 7.26K
EBIT
$ -20.19M$ -37.33M$ -62.51M$ -50.43M$ -28.18M$ -20.54M
EBITDA
$ -18.99M$ -36.30M$ -61.51M$ -51.30M$ -27.56M$ -20.10M
Currency in USD

NexImmune Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis